Foghorn Therapeutics (NASDAQ:FHTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Foghorn Therapeutics (FHTX) operate in?

Foghorn Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Foghorn Therapeutics Stock (NASDAQ: FHTX) stock price, news, charts, stock research, profile.

Open	$4.93
Close	$5.14
Volume / Avg.	443.76K / 162.67K
Day Range	$4.88 - $5.28
52 Wk Range	2.70 - 10.25
Market Cap	$284.39M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	27
Short Interest	2.13%
Days to Cover	10.58

Recent News

Why Foghorn Therapeutics (FHTX) Stock Is Trading Lower

Foghorn Therapeutics shares are trading lower by 20.2% during Monday's session. The company announced it will discontinue independent development of its FHD-286 program.

Henry Khederian

Strength Seen in Foghorn Therapeutics: Can Its 9.5% Jump Turn into More Strength?

Foghorn Therapeutics Inc. (NASDAQ: FHTX) shares rallied 9.5% in the last trading session to close at $9.72. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 43.2% gain over the past four weeks.

Zacks

Wall Street Analysts Think Foghorn Therapeutics Could Surge 81.16%: Read This Before Placing a Bet

Foghorn Therapeutics Inc. (NASDAQ: FHTX) closed the last trading session at $8.28, gaining 35.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.93
Close	$5.14
Volume / Avg.	443.76K / 162.67K
Day Range	$4.88 - $5.28
52 Wk Range	2.70 - 10.25
Market Cap	$284.39M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	27
Short Interest	2.13%
Days to Cover	10.58

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Foghorn Therapeutics (FHTX) stock?

You can purchase shares of Foghorn Therapeutics (NASDAQ:FHTX) through any online brokerage.

View our list of the best stock brokerages

Who are Foghorn Therapeutics (FHTX) competitors?

Other companies in Foghorn Therapeutics’s space includes: Renovaro (NASDAQ:RENB), 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and Sage Therapeutics (NASDAQ:SAGE).

What is the forecast, or price target, for Foghorn Therapeutics (FHTX) stock?

Foghorn Therapeutics has a consensus price target of $14.63.

What is the current price for Foghorn Therapeutics (FHTX)?

The stock price for Foghorn Therapeutics (NASDAQ: FHTX) is $5.14 last updated December 20, 2024 at 4:00 PM EST.

Does Foghorn Therapeutics (FHTX) pay a dividend?

There are no upcoming dividends for Foghorn Therapeutics.

When is Foghorn Therapeutics (NASDAQ:FHTX) reporting earnings?

Foghorn Therapeutics’s Q4 earnings are confirmed for Thursday, March 6, 2025.

Is Foghorn Therapeutics (FHTX) going to split?

There is no upcoming split for Foghorn Therapeutics.

What sector and industry does Foghorn Therapeutics (FHTX) operate in?

Foghorn Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Foghorn Therapeutics

Foghorn Therapeutics (FHTX) Forecast